View DividendBiostar Microtech International マネジメントマネジメント 基準チェック /14現在、CEO に関する十分な情報がありません。主要情報Paul Wang最高経営責任者n/a報酬総額CEO給与比率n/aCEO在任期間36yrsCEOの所有権4.1%経営陣の平均在職期間データなし取締役会の平均在任期間5.1yrs経営陣の近況お知らせ • Mar 10Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city Taiwanお知らせ • Mar 14Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city Taiwanお知らせ • Jun 19Biostar Microtech International Corp. Approves Board AppointmentsBiostar Microtech International Corp. announced that at its Annual General Shareholders' Meeting held on June 18, 2024, The list of persons elected as below: Newly-elected directors: Ming-Yi Wang, Ming-Cheng Wang, Wen-Shone Shiau, Tsung-Hui Tsai. Newly-elected independent directors: Wen-Hsiung Chan, Pao-Chin Chuang, Chiao-Yu Chou.お知らせ • Mar 02Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024. Location: 1F, No.205, Section 3, Beixin Rd., Xindian District New Taipei City Taiwan Agenda: To approve 2023 Business Report; to approve Audit Committee’s Review Report; to approve Business Report and Financial Statement for the year 2023; to approve ratification of the Fiscal 2023 Deficit Compensation Proposal; to approve propose the issuance plan of private placement for common shares; to approve Election of the Company’s Directors; and to approve release the prohibition on directors from participation in competitive business.すべての更新を表示Recent updatesReported Earnings • Aug 14Second quarter 2026 earnings released: EPS: NT$2.07 (vs NT$0.34 loss in 2Q 2025)Second quarter 2026 results: EPS: NT$2.07 (up from NT$0.34 loss in 2Q 2025). Revenue: NT$528.6m (up 17% from 2Q 2025). Net income: NT$368.1m (up NT$428.7m from 2Q 2025). Profit margin: 70% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to NT$32.15, the stock trades at a trailing P/E ratio of 20.6x. Average trailing P/E is 21x in the Tech industry in Taiwan. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to NT$44.00, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 22x in the Tech industry in Taiwan. Total returns to shareholders of 65% over the past three years.Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$52.00, the stock trades at a trailing P/E ratio of 33.3x. Average trailing P/E is 23x in the Tech industry in Taiwan. Total returns to shareholders of 127% over the past three years.Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$50.60, the stock trades at a trailing P/E ratio of 32.4x. Average trailing P/E is 23x in the Tech industry in Taiwan. Total returns to shareholders of 153% over the past three years.Reported Earnings • May 16First quarter 2026 earnings released: EPS: NT$1.00 (vs NT$0.064 in 1Q 2025)First quarter 2026 results: EPS: NT$1.00 (up from NT$0.064 in 1Q 2025). Revenue: NT$434.6m (down 13% from 1Q 2025). Net income: NT$263.1m (up NT$251.8m from 1Q 2025). Profit margin: 61% (up from 2.3% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth.お知らせ • Apr 14Biostar and Netio Technologies Showcase Edge AI Solutions At Japan IT Week SpringBiostar participated with Netio Technologies, a Taiwan-based IPC solution provider, at Japan IT Week Spring 2026, taking place from April 8 to April 10 at Tokyo Big Sight, Japan. Visitors can find Biostar and Netio at West Hall 3, 4F, Booth W20-22, where both companies will showcase their latest innovations in industrial edge computing, connectivity, and on-site AI processing solutions designed for modern industrial environments. Biostar is showcasing its EdgeComp MU-N150 platform, integrated with Netio’s 10BASE-T1L Single-Pair Ethernet technology, to enable long-distance industrial communication with simplified cabling. Supporting communication distances of up to 1 kilometer, the solution transmits both data and power through a single cable, reducing wiring complexity and improving deployment efficiency for distributed edge devices. The combined solution is well-suited for industrial IoT environments where reliable long-distance connectivity is essential. At the heart of the showcase are the EdgeComp MS-NANX and MS-NANO, leveraging the NVIDIA Jetson platform. Powered by the Jetson Orin NX and Orin Nano modules respectively, these compact, high-performance edge computers are specifically engineered to handle complex AI workloads directly at the edge. Designed for ultimate reliability in industrial environments, they provide the robust computing power required for real-time data processing, significantly reducing latency and bandwidth usage. Furthermore, Biostar is also showcasing the BIW88-AHS motherboard, integrated into a robust 4U AI workstation designed for on-site AI computing. The system enables real-time data processing at the edge, reducing reliance on cloud-based infrastructure and allowing for significantly faster response times. By bringing AI capabilities closer to the data source, it supports applications that require immediate analysis and efficient decision-making in industrial and commercial environments. To illustrate these capabilities, the booth features a live demonstration of the workstation powering an advanced Knowledge Management (KM) and intelligent online customer service system. This on-premise AI application streamlines complex corporate tasks, including ISO document management, rapid information retrieval, and internal audit support, delivering highly secure and automated operations directly at the edge. Through its collaboration with Netio Technologies, Biostar is presenting integrated edge computing solutions that combine platform hardware with advanced connectivity technologies. This joint showcase highlights a practical approach to supporting industrial applications that require reliable communication and localized data processing. Visitors can explore these solutions at the booth, demonstrating Biostar’s continued focus on industrial edge and AI computing development. Biostar invites industry professionals, partners, and innovators to visit its booth at Japan IT Week Spring 2026 at Tokyo Big Sight from April 8 to April 10 at West Hall 3, 4F, Booth W20-22, and discover how its edge computing and AI technologies support modern industrial applications.New Risk • Mar 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (24% accrual ratio).Reported Earnings • Mar 17Full year 2025 earnings released: EPS: NT$0.15 (vs NT$0.037 in FY 2024)Full year 2025 results: EPS: NT$0.15 (up from NT$0.037 in FY 2024). Revenue: NT$1.73b (down 14% from FY 2024). Net income: NT$26.2m (up 295% from FY 2024). Profit margin: 1.5% (up from 0.3% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.お知らせ • Mar 10Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city TaiwanReported Earnings • Nov 16Third quarter 2025 earnings released: EPS: NT$0.17 (vs NT$0.14 loss in 3Q 2024)Third quarter 2025 results: EPS: NT$0.17 (up from NT$0.14 loss in 3Q 2024). Revenue: NT$464.8m (down 5.4% from 3Q 2024). Net income: NT$30.3m (up NT$55.7m from 3Q 2024). Profit margin: 6.5% (up from net loss in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 55% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).Reported Earnings • Aug 15Second quarter 2025 earnings released: NT$0.34 loss per share (vs NT$0.049 profit in 2Q 2024)Second quarter 2025 results: NT$0.34 loss per share (down from NT$0.049 profit in 2Q 2024). Revenue: NT$452.4m (down 14% from 2Q 2024). Net loss: NT$60.5m (down NT$69.3m from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance.Reported Earnings • May 14First quarter 2025 earnings released: EPS: NT$0.06 (vs NT$0.19 in 1Q 2024)First quarter 2025 results: EPS: NT$0.06 (down from NT$0.19 in 1Q 2024). Revenue: NT$498.4m (down 21% from 1Q 2024). Net income: NT$11.4m (down 66% from 1Q 2024). Profit margin: 2.3% (down from 5.3% in 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • May 13Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to NT$20.15. The fair value is estimated to be NT$25.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.5% over the last 3 years. Meanwhile, the company has become profitable.お知らせ • Apr 29Biostar Microtech International Corp. to Report Q1, 2025 Results on May 06, 2025Biostar Microtech International Corp. announced that they will report Q1, 2025 results on May 06, 2025New Risk • Apr 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: NT$3.09b (US$93.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (NT$3.09b market cap, or US$93.5m).New Risk • Apr 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 1,198% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company.Buy Or Sell Opportunity • Mar 28Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 17% to NT$21.80. The fair value is estimated to be NT$27.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.5% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • Mar 20Full year 2024 earnings released: EPS: NT$0.04 (vs NT$0.64 loss in FY 2023)Full year 2024 results: EPS: NT$0.04 (up from NT$0.64 loss in FY 2023). Revenue: NT$2.02b (down 14% from FY 2023). Net income: NT$6.62m (up NT$120.0m from FY 2023). Profit margin: 0.3% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance.お知らせ • Mar 14Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city TaiwanNew Risk • Nov 19New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 15% per year over the past 5 years.分析記事 • Nov 15Biostar Microtech International Corp.'s (TWSE:2399) 27% Share Price Plunge Could Signal Some RiskThe Biostar Microtech International Corp. ( TWSE:2399 ) share price has softened a substantial 27% over the previous 30...分析記事 • Sep 16Biostar Microtech International Corp. (TWSE:2399) Stock Rockets 26% As Investors Are Less Pessimistic Than ExpectedBiostar Microtech International Corp. ( TWSE:2399 ) shares have had a really impressive month, gaining 26% after a...New Risk • Aug 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: NT$0.05 (vs NT$0.10 in 2Q 2023)Second quarter 2024 results: EPS: NT$0.05 (down from NT$0.10 in 2Q 2023). Revenue: NT$527.5m (down 2.5% from 2Q 2023). Net income: NT$8.79m (down 53% from 2Q 2023). Profit margin: 1.7% (down from 3.4% in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 113 percentage points per year, which is a significant difference in performance.お知らせ • Jul 31Biostar Microtech International Corp. to Report Q2, 2024 Results on Aug 07, 2024Biostar Microtech International Corp. announced that they will report Q2, 2024 results on Aug 07, 2024お知らせ • Jun 19Biostar Microtech International Corp. Approves Board AppointmentsBiostar Microtech International Corp. announced that at its Annual General Shareholders' Meeting held on June 18, 2024, The list of persons elected as below: Newly-elected directors: Ming-Yi Wang, Ming-Cheng Wang, Wen-Shone Shiau, Tsung-Hui Tsai. Newly-elected independent directors: Wen-Hsiung Chan, Pao-Chin Chuang, Chiao-Yu Chou.Reported Earnings • May 19First quarter 2024 earnings released: EPS: NT$0.19 (vs NT$0.15 in 1Q 2023)First quarter 2024 results: EPS: NT$0.19 (up from NT$0.15 in 1Q 2023). Revenue: NT$628.1m (down 9.0% from 1Q 2023). Net income: NT$33.1m (up 26% from 1Q 2023). Profit margin: 5.3% (up from 3.8% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance.お知らせ • Apr 28Biostar Microtech International Corp. to Report Q1, 2024 Results on May 03, 2024Biostar Microtech International Corp. announced that they will report Q1, 2024 results on May 03, 2024Reported Earnings • Mar 22Full year 2023 earnings released: NT$0.64 loss per share (vs NT$0.072 profit in FY 2022)Full year 2023 results: NT$0.64 loss per share (down from NT$0.072 profit in FY 2022). Revenue: NT$2.34b (up 4.8% from FY 2022). Net loss: NT$113.4m (down NT$126.2m from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.お知らせ • Mar 02Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024. Location: 1F, No.205, Section 3, Beixin Rd., Xindian District New Taipei City Taiwan Agenda: To approve 2023 Business Report; to approve Audit Committee’s Review Report; to approve Business Report and Financial Statement for the year 2023; to approve ratification of the Fiscal 2023 Deficit Compensation Proposal; to approve propose the issuance plan of private placement for common shares; to approve Election of the Company’s Directors; and to approve release the prohibition on directors from participation in competitive business.New Risk • Feb 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: NT$0.10 (vs NT$0.077 loss in 2Q 2022)Second quarter 2023 results: EPS: NT$0.10 (up from NT$0.077 loss in 2Q 2022). Revenue: NT$540.8m (up 9.8% from 2Q 2022). Net income: NT$18.6m (up NT$32.4m from 2Q 2022). Profit margin: 3.4% (up from net loss in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.Reported Earnings • Mar 30Full year 2022 earnings released: EPS: NT$0.07 (vs NT$2.03 in FY 2021)Full year 2022 results: EPS: NT$0.07 (down from NT$2.03 in FY 2021). Revenue: NT$2.24b (down 19% from FY 2021). Net income: NT$12.9m (down 96% from FY 2021). Profit margin: 0.6% (down from 13% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 16Third quarter 2022 earnings released: EPS: NT$0.18 (vs NT$0.33 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.18 (down from NT$0.33 in 3Q 2021). Revenue: NT$545.6m (down 20% from 3Q 2021). Net income: NT$31.8m (down 46% from 3Q 2021). Profit margin: 5.8% (down from 8.6% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 13Third quarter 2022 earnings released: EPS: NT$0.18 (vs NT$0.33 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.18 (down from NT$0.33 in 3Q 2021). Revenue: NT$545.6m (down 20% from 3Q 2021). Net income: NT$31.8m (down 46% from 3Q 2021). Profit margin: 5.8% (down from 8.6% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$11.60, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 12x in the Tech industry in Taiwan. Total returns to shareholders of 20% over the past three years.Buying Opportunity • Aug 18Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be NT$20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Meanwhile, the company has become profitable.Upcoming Dividend • Aug 11Upcoming dividend of NT$1.20 per shareEligible shareholders must have bought the stock before 18 August 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 7.8%. Within top quartile of Taiwanese dividend payers (6.6%). In line with average of industry peers (7.3%).Buying Opportunity • Jul 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be NT$20.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 19% share price gain to NT$16.60, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 13x in the Tech industry in Taiwan. Total returns to shareholders of 41% over the past three years.Buying Opportunity • Jun 17Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 28%. The fair value is estimated to be NT$20.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable.Reported Earnings • May 19First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: NT$0.21 (down from NT$0.39 in 1Q 2021). Revenue: NT$690.8m (up 16% from 1Q 2021). Net income: NT$37.9m (down 45% from 1Q 2021). Profit margin: 5.5% (down from 12% in 1Q 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the last 3 years on average, earnings per share has increased by 114% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 03Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: NT$2.03 (up from NT$0.78 in FY 2020). Revenue: NT$2.77b (up 32% from FY 2020). Net income: NT$361.7m (up 161% from FY 2020). Profit margin: 13% (up from 6.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Dec 23Investor sentiment improved over the past weekAfter last week's 18% share price gain to NT$27.00, the stock trades at a trailing P/E ratio of 15.5x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total returns to shareholders of 181% over the past three years.Reported Earnings • Nov 16Third quarter 2021 earnings released: EPS NT$0.33 (vs NT$0.48 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$679.9m (down 1.0% from 3Q 2020). Net income: NT$58.5m (down 32% from 3Q 2020). Profit margin: 8.6% (down from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Oct 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to NT$21.60, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 15x in the Tech industry in Taiwan. Total returns to shareholders of 120% over the past three years.Valuation Update With 7 Day Price Move • Aug 17Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$21.00, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total returns to shareholders of 61% over the past three years.Upcoming Dividend • Aug 10Upcoming dividend of NT$0.40 per shareEligible shareholders must have bought the stock before 17 August 2021. Payment date: 17 September 2021. Trailing yield: 1.5%. Lower than top quartile of Taiwanese dividend payers (5.0%). Lower than average of industry peers (5.2%).Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$28.90, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total returns to shareholders of 70% over the past three years.Reported Earnings • May 15First quarter 2021 earnings released: EPS NT$0.39 (vs NT$0.18 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$595.5m (up 43% from 1Q 2020). Net income: NT$68.8m (up NT$100.2m from 1Q 2020). Profit margin: 12% (up from net loss in 1Q 2020). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to NT$21.75, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 15x in the Tech industry in Taiwan. Total returns to shareholders of 25% over the past three years.Valuation Update With 7 Day Price Move • Apr 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$30.65, the stock trades at a trailing P/E ratio of 39.4x. Average trailing P/E is 18x in the Tech industry in Taiwan. Total returns to shareholders of 59% over the past three years.Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improved over the past weekAfter last week's 20% share price gain to NT$33.50, the stock trades at a trailing P/E ratio of 43.2x. Average trailing P/E is 17x in the Tech industry in Taiwan. Total returns to shareholders of 54% over the past three years.Reported Earnings • Apr 01Full year 2020 earnings released: EPS NT$0.78 (vs NT$0.042 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: NT$2.10b (down 7.7% from FY 2019). Net income: NT$138.4m (up NT$131.0m from FY 2019). Profit margin: 6.6% (up from 0.3% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 11% per year.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$19.90, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total loss to shareholders of 17% over the past three years.Is New 90 Day High Low • Mar 16New 90-day high: NT$19.00The company is up 15% from a price of NT$16.55 on 16 December 2020. Performed similarly to the Taiwanese market which is up 15% over the last 90 days. Exceeded the Tech industry, which is up 13% over the same period.Valuation Update With 7 Day Price Move • Feb 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$18.50, the stock is trading at a trailing P/E ratio of 15.9x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 15x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 16%.分析記事 • Feb 11The Biostar Microtech International (TPE:2399) Share Price Is Up 93% And Shareholders Are Holding OnIf you want to compound wealth in the stock market, you can do so by buying an index fund. But you can do a lot better...Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$15.65, the stock is trading at a trailing P/E ratio of 13.5x, up from the previous P/E ratio of 11.7x. This compares to an average P/E of 15x in the Tech industry in Taiwan. Total return to shareholders over the past three years is a loss of 4.1%.Is New 90 Day High Low • Jan 20New 90-day low: NT$13.65The company is down 9.0% from its price of NT$14.95 on 22 October 2020. The Taiwanese market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 14% over the same period.分析記事 • Dec 20We're Not So Sure You Should Rely on Biostar Microtech International's (TPE:2399) Statutory EarningsBroadly speaking, profitable businesses are less risky than unprofitable ones. That said, the current statutory profit...Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$18.70, the stock is trading at a trailing P/E ratio of 16.1x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 14x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 38%.Reported Earnings • Nov 17Third quarter 2020 earnings released: EPS NT$0.49The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$686.9m (up 19% from 3Q 2019). Net income: NT$86.4m (up NT$75.7m from 3Q 2019). Profit margin: 13% (up from 1.9% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.Is New 90 Day High Low • Nov 13New 90-day high: NT$17.30The company is up 82% from its price of NT$9.49 on 14 August 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is down 5.0% over the same period.Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 16% share price gain to NT$17.05, the stock is trading at a trailing P/E ratio of 29.7x, up from the previous P/E ratio of 25.6x. This compares to an average P/E of 16x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 50%.Is New 90 Day High Low • Oct 28New 90-day high: NT$15.50The company is up 58% from its price of NT$9.78 on 30 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is flat over the same period.Valuation Update With 7 Day Price Move • Oct 22Market bids up stock over the past weekAfter last week's 19% share price gain to NT$14.95, the stock is trading at a trailing P/E ratio of 26x, up from the previous P/E ratio of 21.8x. This compares to an average P/E of 16x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 13%.Valuation Update With 7 Day Price Move • Oct 14Market bids up stock over the past weekAfter last week's 16% share price gain to NT$13.00, the stock is trading at a trailing P/E ratio of 22.6x, up from the previous P/E ratio of 19.6x. This compares to an average P/E of 16x in the Tech industry in Taiwan. Total return to shareholders over the past three years is a loss of 1.9%.Is New 90 Day High Low • Oct 13New 90-day high: NT$12.40The company is up 24% from its price of NT$10.00 on 15 July 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is down 1.0% over the same period.Is New 90 Day High Low • Sep 21New 90-day high: NT$12.35The company is up 26% from its price of NT$9.82 on 23 June 2020. The Taiwanese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is up 3.0% over the same period.CEO報酬分析Biostar Microtech International の収益と比較して、Paul Wang の報酬はどのように変化したか？日付総報酬給与会社業績Jun 30 2026n/an/aNT$707mMar 31 2026n/an/aNT$278mDec 31 2025n/an/aNT$26mSep 30 2025n/an/a-NT$29mJun 30 2025n/an/a-NT$84mMar 31 2025n/an/a-NT$15mDec 31 2024NT$4mNT$3mNT$7m報酬と市場: Paulの 総報酬 がTW市場の同規模の企業と比較して妥当かどうかを判断するにはデータが不十分です。報酬と収益: Paulの報酬と会社の業績を比較するにはデータが不十分です。CEOPaul Wang 36yrs在職期間NT$4,053,000報酬Mr. Ming-Cheng Wang, also known as Paul, is President and Director since August 29, 1990 of Biostar Microtech International Corp.取締役名称ポジション在職期間報酬所有権Ming-Cheng WangPresident & Director36yrsNT$4.05m4.12% NT$ 325.9mWen-Hsiung ChanIndependent Director11.2yrsNT$404.00kデータなしYu-Chou ChiaoIndependent Director2.2yrsNT$211.00kデータなしMing-Yi WangChairman36yrsNT$4.19m4.69% NT$ 371.5mTsung-Hui TsaiDirector5.1yrsNT$404.00k0.0031% NT$ 243.0kWen-Shone ShiauDirector5.1yrsNT$394.00kデータなしPao Chin ChuangIndependent Director5.1yrsNT$394.00kデータなしもっと見る5.1yrs平均在職期間経験豊富なボード: 2399の 取締役会 は 経験豊富 であると考えられます ( 5.1年の平均在任期間)。View Ownership企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/21 07:54終値2026/08/21 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Biostar Microtech International Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Rui TsaiCapital Securities Corporation
お知らせ • Mar 10Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city Taiwan
お知らせ • Mar 14Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city Taiwan
お知らせ • Jun 19Biostar Microtech International Corp. Approves Board AppointmentsBiostar Microtech International Corp. announced that at its Annual General Shareholders' Meeting held on June 18, 2024, The list of persons elected as below: Newly-elected directors: Ming-Yi Wang, Ming-Cheng Wang, Wen-Shone Shiau, Tsung-Hui Tsai. Newly-elected independent directors: Wen-Hsiung Chan, Pao-Chin Chuang, Chiao-Yu Chou.
お知らせ • Mar 02Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024. Location: 1F, No.205, Section 3, Beixin Rd., Xindian District New Taipei City Taiwan Agenda: To approve 2023 Business Report; to approve Audit Committee’s Review Report; to approve Business Report and Financial Statement for the year 2023; to approve ratification of the Fiscal 2023 Deficit Compensation Proposal; to approve propose the issuance plan of private placement for common shares; to approve Election of the Company’s Directors; and to approve release the prohibition on directors from participation in competitive business.
Reported Earnings • Aug 14Second quarter 2026 earnings released: EPS: NT$2.07 (vs NT$0.34 loss in 2Q 2025)Second quarter 2026 results: EPS: NT$2.07 (up from NT$0.34 loss in 2Q 2025). Revenue: NT$528.6m (up 17% from 2Q 2025). Net income: NT$368.1m (up NT$428.7m from 2Q 2025). Profit margin: 70% (up from net loss in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 112% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to NT$32.15, the stock trades at a trailing P/E ratio of 20.6x. Average trailing P/E is 21x in the Tech industry in Taiwan. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Jul 13Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to NT$44.00, the stock trades at a trailing P/E ratio of 28.2x. Average trailing P/E is 22x in the Tech industry in Taiwan. Total returns to shareholders of 65% over the past three years.
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$52.00, the stock trades at a trailing P/E ratio of 33.3x. Average trailing P/E is 23x in the Tech industry in Taiwan. Total returns to shareholders of 127% over the past three years.
Valuation Update With 7 Day Price Move • May 26Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$50.60, the stock trades at a trailing P/E ratio of 32.4x. Average trailing P/E is 23x in the Tech industry in Taiwan. Total returns to shareholders of 153% over the past three years.
Reported Earnings • May 16First quarter 2026 earnings released: EPS: NT$1.00 (vs NT$0.064 in 1Q 2025)First quarter 2026 results: EPS: NT$1.00 (up from NT$0.064 in 1Q 2025). Revenue: NT$434.6m (down 13% from 1Q 2025). Net income: NT$263.1m (up NT$251.8m from 1Q 2025). Profit margin: 61% (up from 2.3% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has only increased by 41% per year, which means it is significantly lagging earnings growth.
お知らせ • Apr 14Biostar and Netio Technologies Showcase Edge AI Solutions At Japan IT Week SpringBiostar participated with Netio Technologies, a Taiwan-based IPC solution provider, at Japan IT Week Spring 2026, taking place from April 8 to April 10 at Tokyo Big Sight, Japan. Visitors can find Biostar and Netio at West Hall 3, 4F, Booth W20-22, where both companies will showcase their latest innovations in industrial edge computing, connectivity, and on-site AI processing solutions designed for modern industrial environments. Biostar is showcasing its EdgeComp MU-N150 platform, integrated with Netio’s 10BASE-T1L Single-Pair Ethernet technology, to enable long-distance industrial communication with simplified cabling. Supporting communication distances of up to 1 kilometer, the solution transmits both data and power through a single cable, reducing wiring complexity and improving deployment efficiency for distributed edge devices. The combined solution is well-suited for industrial IoT environments where reliable long-distance connectivity is essential. At the heart of the showcase are the EdgeComp MS-NANX and MS-NANO, leveraging the NVIDIA Jetson platform. Powered by the Jetson Orin NX and Orin Nano modules respectively, these compact, high-performance edge computers are specifically engineered to handle complex AI workloads directly at the edge. Designed for ultimate reliability in industrial environments, they provide the robust computing power required for real-time data processing, significantly reducing latency and bandwidth usage. Furthermore, Biostar is also showcasing the BIW88-AHS motherboard, integrated into a robust 4U AI workstation designed for on-site AI computing. The system enables real-time data processing at the edge, reducing reliance on cloud-based infrastructure and allowing for significantly faster response times. By bringing AI capabilities closer to the data source, it supports applications that require immediate analysis and efficient decision-making in industrial and commercial environments. To illustrate these capabilities, the booth features a live demonstration of the workstation powering an advanced Knowledge Management (KM) and intelligent online customer service system. This on-premise AI application streamlines complex corporate tasks, including ISO document management, rapid information retrieval, and internal audit support, delivering highly secure and automated operations directly at the edge. Through its collaboration with Netio Technologies, Biostar is presenting integrated edge computing solutions that combine platform hardware with advanced connectivity technologies. This joint showcase highlights a practical approach to supporting industrial applications that require reliable communication and localized data processing. Visitors can explore these solutions at the booth, demonstrating Biostar’s continued focus on industrial edge and AI computing development. Biostar invites industry professionals, partners, and innovators to visit its booth at Japan IT Week Spring 2026 at Tokyo Big Sight from April 8 to April 10 at West Hall 3, 4F, Booth W20-22, and discover how its edge computing and AI technologies support modern industrial applications.
New Risk • Mar 23New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). High level of non-cash earnings (24% accrual ratio).
Reported Earnings • Mar 17Full year 2025 earnings released: EPS: NT$0.15 (vs NT$0.037 in FY 2024)Full year 2025 results: EPS: NT$0.15 (up from NT$0.037 in FY 2024). Revenue: NT$1.73b (down 14% from FY 2024). Net income: NT$26.2m (up 295% from FY 2024). Profit margin: 1.5% (up from 0.3% in FY 2024). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 18% per year, which means it is well ahead of earnings.
お知らせ • Mar 10Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026Biostar Microtech International Corp., Annual General Meeting, Jun 17, 2026. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city Taiwan
Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: NT$0.17 (vs NT$0.14 loss in 3Q 2024)Third quarter 2025 results: EPS: NT$0.17 (up from NT$0.14 loss in 3Q 2024). Revenue: NT$464.8m (down 5.4% from 3Q 2024). Net income: NT$30.3m (up NT$55.7m from 3Q 2024). Profit margin: 6.5% (up from net loss in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
New Risk • Oct 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 55% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.8% average weekly change).
Reported Earnings • Aug 15Second quarter 2025 earnings released: NT$0.34 loss per share (vs NT$0.049 profit in 2Q 2024)Second quarter 2025 results: NT$0.34 loss per share (down from NT$0.049 profit in 2Q 2024). Revenue: NT$452.4m (down 14% from 2Q 2024). Net loss: NT$60.5m (down NT$69.3m from profit in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 101 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 14First quarter 2025 earnings released: EPS: NT$0.06 (vs NT$0.19 in 1Q 2024)First quarter 2025 results: EPS: NT$0.06 (down from NT$0.19 in 1Q 2024). Revenue: NT$498.4m (down 21% from 1Q 2024). Net income: NT$11.4m (down 66% from 1Q 2024). Profit margin: 2.3% (down from 5.3% in 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • May 13Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 22% to NT$20.15. The fair value is estimated to be NT$25.67, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.5% over the last 3 years. Meanwhile, the company has become profitable.
お知らせ • Apr 29Biostar Microtech International Corp. to Report Q1, 2025 Results on May 06, 2025Biostar Microtech International Corp. announced that they will report Q1, 2025 results on May 06, 2025
New Risk • Apr 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: NT$3.09b (US$93.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (NT$3.09b market cap, or US$93.5m).
New Risk • Apr 01New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 1,198% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. This is currently the only risk that has been identified for the company.
Buy Or Sell Opportunity • Mar 28Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 17% to NT$21.80. The fair value is estimated to be NT$27.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 9.5% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • Mar 20Full year 2024 earnings released: EPS: NT$0.04 (vs NT$0.64 loss in FY 2023)Full year 2024 results: EPS: NT$0.04 (up from NT$0.64 loss in FY 2023). Revenue: NT$2.02b (down 14% from FY 2023). Net income: NT$6.62m (up NT$120.0m from FY 2023). Profit margin: 0.3% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 123 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 14Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025Biostar Microtech International Corp., Annual General Meeting, Jun 20, 2025. Location: 1 floor no,205, sec.3 pei hsin rd., sindian district, new taipei city Taiwan
New Risk • Nov 19New major risk - Revenue and earnings growthEarnings have declined by 15% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 15% per year over the past 5 years.
分析記事 • Nov 15Biostar Microtech International Corp.'s (TWSE:2399) 27% Share Price Plunge Could Signal Some RiskThe Biostar Microtech International Corp. ( TWSE:2399 ) share price has softened a substantial 27% over the previous 30...
分析記事 • Sep 16Biostar Microtech International Corp. (TWSE:2399) Stock Rockets 26% As Investors Are Less Pessimistic Than ExpectedBiostar Microtech International Corp. ( TWSE:2399 ) shares have had a really impressive month, gaining 26% after a...
New Risk • Aug 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: NT$0.05 (vs NT$0.10 in 2Q 2023)Second quarter 2024 results: EPS: NT$0.05 (down from NT$0.10 in 2Q 2023). Revenue: NT$527.5m (down 2.5% from 2Q 2023). Net income: NT$8.79m (down 53% from 2Q 2023). Profit margin: 1.7% (down from 3.4% in 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 113 percentage points per year, which is a significant difference in performance.
お知らせ • Jul 31Biostar Microtech International Corp. to Report Q2, 2024 Results on Aug 07, 2024Biostar Microtech International Corp. announced that they will report Q2, 2024 results on Aug 07, 2024
お知らせ • Jun 19Biostar Microtech International Corp. Approves Board AppointmentsBiostar Microtech International Corp. announced that at its Annual General Shareholders' Meeting held on June 18, 2024, The list of persons elected as below: Newly-elected directors: Ming-Yi Wang, Ming-Cheng Wang, Wen-Shone Shiau, Tsung-Hui Tsai. Newly-elected independent directors: Wen-Hsiung Chan, Pao-Chin Chuang, Chiao-Yu Chou.
Reported Earnings • May 19First quarter 2024 earnings released: EPS: NT$0.19 (vs NT$0.15 in 1Q 2023)First quarter 2024 results: EPS: NT$0.19 (up from NT$0.15 in 1Q 2023). Revenue: NT$628.1m (down 9.0% from 1Q 2023). Net income: NT$33.1m (up 26% from 1Q 2023). Profit margin: 5.3% (up from 3.8% in 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 93 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 28Biostar Microtech International Corp. to Report Q1, 2024 Results on May 03, 2024Biostar Microtech International Corp. announced that they will report Q1, 2024 results on May 03, 2024
Reported Earnings • Mar 22Full year 2023 earnings released: NT$0.64 loss per share (vs NT$0.072 profit in FY 2022)Full year 2023 results: NT$0.64 loss per share (down from NT$0.072 profit in FY 2022). Revenue: NT$2.34b (up 4.8% from FY 2022). Net loss: NT$113.4m (down NT$126.2m from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 02Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024Biostar Microtech International Corp., Annual General Meeting, Jun 18, 2024. Location: 1F, No.205, Section 3, Beixin Rd., Xindian District New Taipei City Taiwan Agenda: To approve 2023 Business Report; to approve Audit Committee’s Review Report; to approve Business Report and Financial Statement for the year 2023; to approve ratification of the Fiscal 2023 Deficit Compensation Proposal; to approve propose the issuance plan of private placement for common shares; to approve Election of the Company’s Directors; and to approve release the prohibition on directors from participation in competitive business.
New Risk • Feb 29New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 18Second quarter 2023 earnings released: EPS: NT$0.10 (vs NT$0.077 loss in 2Q 2022)Second quarter 2023 results: EPS: NT$0.10 (up from NT$0.077 loss in 2Q 2022). Revenue: NT$540.8m (up 9.8% from 2Q 2022). Net income: NT$18.6m (up NT$32.4m from 2Q 2022). Profit margin: 3.4% (up from net loss in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 30Full year 2022 earnings released: EPS: NT$0.07 (vs NT$2.03 in FY 2021)Full year 2022 results: EPS: NT$0.07 (down from NT$2.03 in FY 2021). Revenue: NT$2.24b (down 19% from FY 2021). Net income: NT$12.9m (down 96% from FY 2021). Profit margin: 0.6% (down from 13% in FY 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 26% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 16Third quarter 2022 earnings released: EPS: NT$0.18 (vs NT$0.33 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.18 (down from NT$0.33 in 3Q 2021). Revenue: NT$545.6m (down 20% from 3Q 2021). Net income: NT$31.8m (down 46% from 3Q 2021). Profit margin: 5.8% (down from 8.6% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 13Third quarter 2022 earnings released: EPS: NT$0.18 (vs NT$0.33 in 3Q 2021)Third quarter 2022 results: EPS: NT$0.18 (down from NT$0.33 in 3Q 2021). Revenue: NT$545.6m (down 20% from 3Q 2021). Net income: NT$31.8m (down 46% from 3Q 2021). Profit margin: 5.8% (down from 8.6% in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$11.60, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 12x in the Tech industry in Taiwan. Total returns to shareholders of 20% over the past three years.
Buying Opportunity • Aug 18Now 25% undervalued after recent price dropOver the last 90 days, the stock is down 16%. The fair value is estimated to be NT$20.11, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Meanwhile, the company has become profitable.
Upcoming Dividend • Aug 11Upcoming dividend of NT$1.20 per shareEligible shareholders must have bought the stock before 18 August 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 7.8%. Within top quartile of Taiwanese dividend payers (6.6%). In line with average of industry peers (7.3%).
Buying Opportunity • Jul 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 19%. The fair value is estimated to be NT$20.68, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Jul 19Investor sentiment improved over the past weekAfter last week's 19% share price gain to NT$16.60, the stock trades at a trailing P/E ratio of 8.9x. Average trailing P/E is 13x in the Tech industry in Taiwan. Total returns to shareholders of 41% over the past three years.
Buying Opportunity • Jun 17Now 23% undervalued after recent price dropOver the last 90 days, the stock is down 28%. The fair value is estimated to be NT$20.59, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 13% over the last 3 years. Meanwhile, the company has become profitable.
Reported Earnings • May 19First quarter 2022 earnings: EPS and revenues miss analyst expectationsFirst quarter 2022 results: EPS: NT$0.21 (down from NT$0.39 in 1Q 2021). Revenue: NT$690.8m (up 16% from 1Q 2021). Net income: NT$37.9m (down 45% from 1Q 2021). Profit margin: 5.5% (down from 12% in 1Q 2021). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the last 3 years on average, earnings per share has increased by 114% per year but the company’s share price has only increased by 21% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 03Full year 2021 earnings: EPS and revenues miss analyst expectationsFull year 2021 results: EPS: NT$2.03 (up from NT$0.78 in FY 2020). Revenue: NT$2.77b (up 32% from FY 2020). Net income: NT$361.7m (up 161% from FY 2020). Profit margin: 13% (up from 6.6% in FY 2020). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 75%. Over the last 3 years on average, earnings per share has increased by 116% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment improved over the past weekAfter last week's 18% share price gain to NT$27.00, the stock trades at a trailing P/E ratio of 15.5x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total returns to shareholders of 181% over the past three years.
Reported Earnings • Nov 16Third quarter 2021 earnings released: EPS NT$0.33 (vs NT$0.48 in 3Q 2020)The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$679.9m (down 1.0% from 3Q 2020). Net income: NT$58.5m (down 32% from 3Q 2020). Profit margin: 8.6% (down from 13% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 108% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Oct 19Investor sentiment improved over the past weekAfter last week's 16% share price gain to NT$21.60, the stock trades at a trailing P/E ratio of 11.4x. Average trailing P/E is 15x in the Tech industry in Taiwan. Total returns to shareholders of 120% over the past three years.
Valuation Update With 7 Day Price Move • Aug 17Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to NT$21.00, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total returns to shareholders of 61% over the past three years.
Upcoming Dividend • Aug 10Upcoming dividend of NT$0.40 per shareEligible shareholders must have bought the stock before 17 August 2021. Payment date: 17 September 2021. Trailing yield: 1.5%. Lower than top quartile of Taiwanese dividend payers (5.0%). Lower than average of industry peers (5.2%).
Valuation Update With 7 Day Price Move • Jun 02Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$28.90, the stock trades at a trailing P/E ratio of 21.4x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total returns to shareholders of 70% over the past three years.
Reported Earnings • May 15First quarter 2021 earnings released: EPS NT$0.39 (vs NT$0.18 loss in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$595.5m (up 43% from 1Q 2020). Net income: NT$68.8m (up NT$100.2m from 1Q 2020). Profit margin: 12% (up from net loss in 1Q 2020). Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 14Investor sentiment deteriorated over the past weekAfter last week's 24% share price decline to NT$21.75, the stock trades at a trailing P/E ratio of 28x. Average trailing P/E is 15x in the Tech industry in Taiwan. Total returns to shareholders of 25% over the past three years.
Valuation Update With 7 Day Price Move • Apr 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to NT$30.65, the stock trades at a trailing P/E ratio of 39.4x. Average trailing P/E is 18x in the Tech industry in Taiwan. Total returns to shareholders of 59% over the past three years.
Valuation Update With 7 Day Price Move • Apr 06Investor sentiment improved over the past weekAfter last week's 20% share price gain to NT$33.50, the stock trades at a trailing P/E ratio of 43.2x. Average trailing P/E is 17x in the Tech industry in Taiwan. Total returns to shareholders of 54% over the past three years.
Reported Earnings • Apr 01Full year 2020 earnings released: EPS NT$0.78 (vs NT$0.042 in FY 2019)The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: NT$2.10b (down 7.7% from FY 2019). Net income: NT$138.4m (up NT$131.0m from FY 2019). Profit margin: 6.6% (up from 0.3% in FY 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 12% per year whereas the company’s share price has increased by 11% per year.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$19.90, the stock trades at a trailing P/E ratio of 17.1x. Average trailing P/E is 16x in the Tech industry in Taiwan. Total loss to shareholders of 17% over the past three years.
Is New 90 Day High Low • Mar 16New 90-day high: NT$19.00The company is up 15% from a price of NT$16.55 on 16 December 2020. Performed similarly to the Taiwanese market which is up 15% over the last 90 days. Exceeded the Tech industry, which is up 13% over the same period.
Valuation Update With 7 Day Price Move • Feb 18Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$18.50, the stock is trading at a trailing P/E ratio of 15.9x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 15x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 16%.
分析記事 • Feb 11The Biostar Microtech International (TPE:2399) Share Price Is Up 93% And Shareholders Are Holding OnIf you want to compound wealth in the stock market, you can do so by buying an index fund. But you can do a lot better...
Valuation Update With 7 Day Price Move • Jan 29Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$15.65, the stock is trading at a trailing P/E ratio of 13.5x, up from the previous P/E ratio of 11.7x. This compares to an average P/E of 15x in the Tech industry in Taiwan. Total return to shareholders over the past three years is a loss of 4.1%.
Is New 90 Day High Low • Jan 20New 90-day low: NT$13.65The company is down 9.0% from its price of NT$14.95 on 22 October 2020. The Taiwanese market is up 22% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Tech industry, which is up 14% over the same period.
分析記事 • Dec 20We're Not So Sure You Should Rely on Biostar Microtech International's (TPE:2399) Statutory EarningsBroadly speaking, profitable businesses are less risky than unprofitable ones. That said, the current statutory profit...
Valuation Update With 7 Day Price Move • Dec 18Investor sentiment improved over the past weekAfter last week's 17% share price gain to NT$18.70, the stock is trading at a trailing P/E ratio of 16.1x, up from the previous P/E ratio of 13.8x. This compares to an average P/E of 14x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 38%.
Reported Earnings • Nov 17Third quarter 2020 earnings released: EPS NT$0.49The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$686.9m (up 19% from 3Q 2019). Net income: NT$86.4m (up NT$75.7m from 3Q 2019). Profit margin: 13% (up from 1.9% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings.
Is New 90 Day High Low • Nov 13New 90-day high: NT$17.30The company is up 82% from its price of NT$9.49 on 14 August 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is down 5.0% over the same period.
Valuation Update With 7 Day Price Move • Nov 09Market bids up stock over the past weekAfter last week's 16% share price gain to NT$17.05, the stock is trading at a trailing P/E ratio of 29.7x, up from the previous P/E ratio of 25.6x. This compares to an average P/E of 16x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 50%.
Is New 90 Day High Low • Oct 28New 90-day high: NT$15.50The company is up 58% from its price of NT$9.78 on 30 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is flat over the same period.
Valuation Update With 7 Day Price Move • Oct 22Market bids up stock over the past weekAfter last week's 19% share price gain to NT$14.95, the stock is trading at a trailing P/E ratio of 26x, up from the previous P/E ratio of 21.8x. This compares to an average P/E of 16x in the Tech industry in Taiwan. Total returns to shareholders over the past three years are 13%.
Valuation Update With 7 Day Price Move • Oct 14Market bids up stock over the past weekAfter last week's 16% share price gain to NT$13.00, the stock is trading at a trailing P/E ratio of 22.6x, up from the previous P/E ratio of 19.6x. This compares to an average P/E of 16x in the Tech industry in Taiwan. Total return to shareholders over the past three years is a loss of 1.9%.
Is New 90 Day High Low • Oct 13New 90-day high: NT$12.40The company is up 24% from its price of NT$10.00 on 15 July 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is down 1.0% over the same period.
Is New 90 Day High Low • Sep 21New 90-day high: NT$12.35The company is up 26% from its price of NT$9.82 on 23 June 2020. The Taiwanese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Tech industry, which is up 3.0% over the same period.